Background: Transcutaneous bilirubin (TcB) devices are commonly used for screening of hyperbilirubinemia in term and near-term infants not exposed to phototherapy. However, the accuracy of TcB devices in infants exposed to phototherapy is unclear. Objectives: To conduct a systematic review of studies comparing TcB devices with total serum bilirubin (TSB) in infants receiving phototherapy or in the postphototherapy phase. Methods: MEDLINE, EMBASE, Cochrane Library, CINAHL and Scopus databases (from inception to May 8, 2014) were searched. Additional citations were identified from the bibliography of selected articles and from the abstracts of conference proceedings. The studies were included if they compared TcB results with TSB in term and near-term infants during phototherapy or after discontinuation of phototherapy. Two reviewers independently assessed studies for inclusion, and discrepancies were resolved with consensus. Risk of bias was assessed using the QUADAS-2 tool. Results: Fourteen studies were identified. The pooled estimates of correlation coefficients (r) during phototherapy were: covered sites 0.71 (95% CI 0.64-0.77, 11 studies), uncovered sites 0.65 (95% CI 0.55-0.74), 8 studies), forehead 0.70 (95% CI 0.64-0.75, 12 studies) and sternum 0.64 (95% CI 0.43-0.77, 5 studies). Two studies also provided results as Bland-Altman difference plots (mean TcB-TSB differences -29.2 and 30 µmol/l, respectively). The correlation coefficient improved marginally in the postphototherapy phase (r = 0.72, 95% CI 0.64-0.78, 4 studies). Conclusion: We found a moderate correlation between TcB and TSB during phototherapy with a marginal improvement in the postphototherapy phase. Further research is needed before the use of TcB devices can be recommended for these settings.

1.
Bhutani VK, Stark AR, Lazzeroni LC, Poland R, Gourley GR, Kazmierczak S, et al: Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy. J Pediatr 2013;162:477-482.
2.
Keren R, Tremont K, Luan X, Cnaan A: Visual assessment of jaundice in term and late preterm infants. Arch Dis Child Fetal Neonatal Ed 2009;94:F317-F322.
3.
Sarici SU, Serdar MA, Korkmaz A, Erdem G, Oran O, Tekinalp G, et al: Incidence, course, and prediction of hyperbilirubinemia in near-term and term newborns. Pediatrics 2004;113:775-780.
4.
Kramer LI: Advancement of dermal icterus in the jaundiced newborn. Am J Dis Child 1969;118:454-458.
5.
Moyer VA, Ahn C, Sneed S: Accuracy of clinical judgment in neonatal jaundice. Arch Pediatr Adolesc Med 2000;154:391-394.
6.
Szabo P, Wolf M, Bucher HU, Fauchere JC, Haensse D, Arlettaz R: Detection of hyperbilirubinaemia in jaundiced full-term neonates by eye or by bilirubinometer? Eur J Pediatr 2004;163:722-727.
7.
Anand KJ: Pain, plasticity, and premature birth: a prescription for permanent suffering? Nat Med 2000;6:971-973.
8.
El-Beshbishi SN, Shattuck KE, Mohammad AA, Petersen JR: Hyperbilirubinemia and transcutaneous bilirubinometry. Clin Chem 2009;55:1280-1287.
9.
Bhutani VK, Gourley GR, Adler S, Kreamer B, Dalin C, Johnson LH: Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics 2000;106:E17.
10.
Teran CG, Mohamed T, Casey J: Transcutaneous bilirubinometry: comparison of two multiwavelength devices in healthy term newborns. Eur J Pediatr 2011;170:1485.
11.
Fouzas S, Karatza AA, Skylogianni E, Mantagou L, Varvarigou A: Transcutaneous bilirubin levels in late preterm neonates. J Pediatr 2010;157:762-766.
12.
Maisels MJ, Ostrea EM Jr, Touch S, Clune SE, Cepeda E, Kring E, et al: Evaluation of a new transcutaneous bilirubinometer. Pediatrics 2004;113:1628-1635.
13.
Rubaltelli FF, Gourley GR, Loskamp N, Modi N, Roth-Kleiner M, Sender A, et al: Transcutaneous bilirubin measurement: a multicenter evaluation of a new device. Pediatrics 2001;107:1264-1271.
14.
Nagar G, Vandermeer B, Campbell S, Kumar M: Reliability of transcutaneous bilirubin devices in preterm infants: a systematic review. Pediatrics 2013;132:871-881.
15.
American Academy of Pediatrics Subcommittee on Hyperbilirubinemia: Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297-316.
16.
Jackson CL, Tudehope D, Willis L, Law T, Venz J: Home phototherapy for neonatal jaundice - technology and teamwork meeting consumer and service need. Aust Health Rev 2000;23:162-168.
17.
Reyes CA, Stednitz DR, Hahn C, Mutchie KD, McCullough SR, Kronberg K: Evaluation of the BiliChek being used on hyperbilirubinemic newborns undergoing home phototherapy. Arch Pathol Lab Med 2008;132:684-689.
18.
Walls M, Wright A, Fowlie P, Irvine L, Hume R: Home phototherapy in the United Kingdom. Arch Dis Child Fetal Neonatal Ed 2004;89:F282.
19.
Zainab K, Adlina S: Effectiveness of home versus hospital phototherapy for term infants with uncomplicated hyperbilirubinemia: a pilot study in Pahang, Malaysia. Med J Malaysia 2004;59:395-401.
20.
Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;i:307-310.
21.
Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al: QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011;155:529-536.
22.
Peyton PJ, Chong SW: Minimally invasive measurement of cardiac output during surgery and critical care: a meta-analysis of accuracy and precision. Anesthesiology 2010;113:1220-1235.
23.
Rylance S, Yan J, Molyneux E: Can transcutaneous bilirubinometry safely guide phototherapy treatment of neonatal jaundice in Malawi? Paediatr Int Child Health 2014;34:101-107.
24.
Dominguez OF, Ormazabal Ramos JC, Martin ZM, Domenech ME: Transcutaneous bilirubinometry: correlation of the reading site obtained with spectrophotometry and diazoreaction technique (in Spanish). An Esp Pediatr 1993;39:438-440.
25.
Felc Z: Improvement of conventional transcutaneous bilirubinometry results in term newborn infants. Am J Perinatol 2005;22:173-179.
26.
Fok TF, Lau SP, Hui CW, Fung KP, Wan CW: Transcutaneous bilirubinometer: its use in Chinese term infants and the effect of haematocrit and phototherapy on the TcB index. Aust Paediatr J 1986;22:107-109.
27.
Galletto P, Vignolo LC, Farina D, Gavinelli R: Supervision of neonatal jaundice by use of the transcutaneous bilirubinometer (in Italian). Minerva Pediatr 1983;35:51-55.
28.
Hannemann RE, Schreiner RL, DeWitt DP, Norris SA, Glick MR: Evaluation of the Minolta bilirubin meter as a screening device in white and black infants. Pediatrics 1982;69:107-109.
29.
Kumar A, Faridi MM, Singh N, Ahmad SH: Transcutaneous bilirubinometry in the management of bilirubinemia in term neonates. Indian J Med Res 1994;99:227-230.
30.
Mahajan G, Kaushal RK, Sankhyan N, Sharma RL, Nakra M: Transcutaneous bilirubinometer in assessment of neonatal jaundice in northern India. Indian Pediatr 2005;42:41-45.
31.
Rey Galan C, Rianco Galan I, Blanco Joglar J, Gonzalez Mencia G, Enguix Armada A: Clinical application of transcutaneous bilirubin in newborns. Rev Esp Pediatr 1992;48:296-299.
32.
Tan KL, Dong F: Transcutaneous bilirubinometry during and after phototherapy. Acta Paediatr 2003;92:327-331.
33.
Vaisman S, Hinrichsen M: Clinical trial of a transcutaneous bilirubinometer (in Spanish). Rev Chil Pediatr 1983;54:83-86.
34.
Juster-Reicher A, Flidel-Rimon O, Rozin I, Shinwell ES: Correlation of transcutaneous bilirubinometry (TcB) and total serum bilirubin (TsB) levels after phototherapy. J Matern Fetal Neonatal Med 2015;28:1329-1331.
35.
Panburana J, Boonkasidach S, Rearkyai S: Accuracy of transcutaneous bilirubinometry compared to total serum bilirubin measurement. J Med Assoc Thai 2010;93(suppl 2):S81-S86.
36.
Rehak NN, Cecco SA, Hortin GL: Photolysis of bilirubin in serum specimens exposed to room lighting. Clin Chim Acta 2008;387:181-183.
37.
Taylor R: Interpretation of the correlation coefficient: a basic review. J Diagn Med Sonogr 1990;6:35-39.
38.
Grohmann K, Roser M, Rolinski B, Kadow I, Müller C, Goerlach-Graw A, et al: Bilirubin measurement for neonates: comparison of 9 frequently used methods. Pediatrics 2006;117:1174-1183.
39.
Maisels MJ, Kring E: Transcutaneous bilirubinometry decreases the need for serum bilirubin measurements and saves money. Pediatrics 1997;99:599-601.
40.
Dechartres A, Trinquart L, Boutron I, Ravaud P: Influence of trial sample size on treatment effect estimates: meta-epidemiological study. BMJ 2013;346:f2304.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.